Cornell Pledges to Licensing Frameworks for Rapid Utilization of COVID-19 Technologies
June 29, 2020
Cornell University is dedicated to bringing the University’s scientific discoveries, technological innovations, and medical advances to the marketplace for societal benefit. In these unprecedented times, the immediate need for innovation to help society navigate through the COVID-19 pandemic is imperative. Cornell has joined with other research universities and the Association of University Technology Managers (AUTM) and pledged to the following frameworks to help meet this crucial challenge.
COVID-19 Technology Access Framework
The first is the COVID-19 Technology Access Framework. Led by founding institutions Harvard University, Massachusetts Institute of Technology, Stanford University, Cornell University and many more prestigious institutions have committed to a technology transfer framework to enable rapid utilization of discoveries that may play a role in preventing, diagnosing and treating COVID-19 infection during the pandemic.
AUTM’s COVID-19 Licensing Guidelines
The second initiative is joining with AUTM’s COVID-19 Licensing Guidelines. The AUTM COVID-19 Licensing Guidelines enable and empower technology transfer offices from university and other non-profit research organizations to facilitate a rapid response to the COVID-19 pandemic.